Concepedia

Author

Alberto Russu

Janssen (United States)ORCID

Also Known As

A Russu, A. Russu, Alberto Russu

47

Publications

486

Citations

9

H-Index

7

Concepts

All Affiliations

Janssen (United States)Janssen (Belgium)University of AntwerpZNA Middelheim Hospital
AR

About

Alberto Russu is an author at Janssen (United States) specializing in medicine, pharmacotherapy, and psychopharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

32

2

Pharmacology

1

1

32

3

Psychiatry

1

1

32

4

Psychopharmacology

1

1

32

5

Schizophrenia

1

1

32

Alberto Russu

×

7

Publications

350

Citations

7

H-Index

YearCitations

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

Maarten Timmers, Johannes Streffer, Alberto Russu,

Alzheimer s Research & Therapy

2018

106

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study

Gerald Novak, Johannes Streffer, Maarten Timmers,

Alzheimer s Research & Therapy

2020

98

Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ‐54861911, a potent oral BACE inhibitor

Maarten Timmers, Bianca Van Broeck, Steven Ramael,

Alzheimer s & Dementia Translational Research & Clinical Interventions

2016

59

Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia

Mats O. Magnusson, Mahesh N. Samtani, Elodie L. Plan,

Clinical Pharmacokinetics

2016

32

Alzheimer's disease assessment scale‐cognitive 11‐item progression model in mild‐to‐moderate Alzheimer's disease trials of bapineuzumab

Mahesh N. Samtani, Steven Xu, Alberto Russu,

Alzheimer s & Dementia Translational Research & Clinical Interventions

2015

21

Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations

Alberto Russu, Jennifer Kern Sliwa, Paulien Ravenstijn,

International Journal of Clinical Practice

2018

20

Prospective dose selection and acceleration of paliperidone palmitate 3‐month formulation development using a pharmacometric bridging strategy

Mahesh N. Samtani, Partha Nandy, Paulien Ravenstijn,

British Journal of Clinical Pharmacology

2016

14

Page 1